Cargando…

Antibodies against SARS-CoV-2 Time Course in Patients and Vaccinated Subjects: An Evaluation of the Harmonization of Two Different Methods

The time course of antibodies against SARS-CoV-2 is not yet well elucidated, especially in people who underwent a vaccination campaign. In this study, we measured the antibodies anti-S1 and anti-RBD with two different methods, both in patients and in vaccinated subjects. One hundred and eight specim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dittadi, Ruggero, Seguso, Mara, Bertoli, Isabella, Afshar, Haleh, Carraro, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472184/ https://www.ncbi.nlm.nih.gov/pubmed/34574052 http://dx.doi.org/10.3390/diagnostics11091709

Ejemplares similares

Two SARS-CoV-2 IgG immunoassays comparison and time-course profile of antibodies response
por: Dittadi, Ruggero, et al.
Publicado: (2021)

Harmonization of Determination of SARS-CoV-2 Antibodies: Is It Always Possible?
por: Dittadi, Ruggero
Publicado: (2022)

Harmonization of six quantitative SARS-CoV-2 serological assays using sera of vaccinated subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
por: Villalta, Danilo, et al.
Publicado: (2022)

High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2
por: Menezes, Ana M. B., et al.
Publicado: (2021)

A course in abstract harmonic analysis
por: Folland, Gerald B
Publicado: (1994)

A first course in harmonic analysis
por: Deitmar, Anton
Publicado: (2002)

A first course in harmonic analysis
por: Deitmar, Anton
Publicado: (2005)

A course in abstract harmonic analysis /
por: Folland, G. B.
Publicado: (1995)

Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects
por: Manenti, Alessandro, et al.
Publicado: (2022)

Prevalence of antibodies against SARS-CoV-2 in hemodialysis patients
por: Arteaga-Müller, Giovanna Yazmin, et al.
Publicado: (2021)

Harmonic analysis: a comprehensive course in analysis
por: Simon, Barry
Publicado: (2015)

SARS CoV- 2 vaccination induces antibodies against cardiolipin
por: Krashias, George, et al.
Publicado: (2022)

Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2021)

PReS-FINAL-2005: Prevalence of antinuclear antibodies in schoolchildren across puberty and possible relationship with musculoskeletal pain. A longitudinal study
por: Sperotto, F, et al.
Publicado: (2013)

Antibody response against SARS-CoV-2 in convalescent plasma donors: Can we predict subjects’ eligibility?
por: Prudente, Tiago Paiva, et al.
Publicado: (2022)

A protein interaction map identifies existing drugs targeting SARS-CoV-2
por: Cava, Claudia, et al.
Publicado: (2020)

Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
por: Amodio, Emanuele, et al.
Publicado: (2021)

THE CLINICAL COURSE OF PATIENTS WITH A HISTORY OF ACUTE PERICARDITIS FOLLOWING VACCINATION AGAINST SARS-COV2
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Inactivated Vaccines Against SARS-CoV-2: Neutralizing Antibody Titers in Vaccine Recipients
por: Zhang, Haiying, et al.
Publicado: (2022)

Comparing SARS-CoV-2 neutralizing antibody levels in convalescent unvaccinated, convalescent vaccinated, and naive vaccinated subjects
por: Dulipsingh, Latha, et al.
Publicado: (2023)

SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
por: Mara, Elisabeth, et al.
Publicado: (2022)

Vaccines against SARS‐CoV‐2 are safe to administer in patients with antibodies to pegaspargase
por: Swanson, Hope D., et al.
Publicado: (2022)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Neutralizing and enhancing antibodies against SARS-CoV-2
por: Liu, Yafei, et al.
Publicado: (2022)

Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
por: Ferrari, Davide, et al.
Publicado: (2021)

Nine-month course of SARS-CoV-2 antibodies in individuals with COVID-19 infection
por: Turkkan, Alpaslan, et al.
Publicado: (2022)

Characteristics of Anti-SARS-CoV-2 Antibodies in Recovered COVID-19 Subjects
por: Huynh, Angela, et al.
Publicado: (2021)

Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs
por: Bekliz, Meriem, et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
por: Immordino, Palmira, et al.
Publicado: (2023)

Morphea in two patients after being infected to and being vaccinated against SARS‐CoV‐2 infection
por: Aryanian, Zeinab, et al.
Publicado: (2022)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Diagnostic performances and thresholds: The key to harmonization in serological SARS-CoV-2 assays?
por: Plebani, Mario, et al.
Publicado: (2020)

Vaccines against SARS-COV-2
por: Kim, Jerome H.
Publicado: (2021)

Nasopharyngeal Bacterial Microbiota Composition and SARS-CoV-2 IgG Antibody Maintenance in Asymptomatic/Paucisymptomatic Subjects
por: Ferrari, Luca, et al.
Publicado: (2022)

Strong Neutralizing Antibody Responses to SARS-CoV-2 Variants Following a Single Vaccine Dose in Subjects With Previous SARS-CoV-2 Infection
por: Ekström, Nina, et al.
Publicado: (2022)

Kinetics of the Antibody Response to Boostering With Three Different Vaccines Against SARS-CoV-2
por: Markewitz, Robert, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9ufg7f0oruvah3a5p81r7bt1r7